SEC Form DEFA14A filed by Phathom Pharmaceuticals Inc.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant Filed by a Party other than the Registrant
Check the appropriate box:
☐ Preliminary Proxy Statement
☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐ Definitive Proxy Statement
☒ Definitive Additional Materials
☐ Soliciting Material under §240.14a-12
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
No fee required
☐ Fee paid previously with preliminary materials
☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
PHATHOM PHARMACEUTICALS, INC.2025 Annual Meeting Vote by June 2, 202511:59 PM ETPHATHOM PHARMACEUTICALS, INC.100 CAMPUS DRIVE, SUITE 102FLORHAM PARK, NJ 07932V67645-P29094You invested in PHATHOM PHARMACEUTICALS, INC. and it’s time to vote!You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the stockholder meeting to be held on June 3, 2025.Get informed before you vote View the Annual Report and Notice and Proxy Statement online OR you can receive a free paper or email copy of the material(s) by requesting prior to May 20, 2025. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to [email protected]. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.For complete information and to vote, visit www.ProxyVote.com Control #Vote Virtually at the Meeting*June 3, 202511:30 AM EDT Smartphone users Point your camera here and vote without entering a control number Virtually at:www.virtualshareholdermeeting.com/PHAT2025*Please check the meeting materials for any special requirements for meeting attendance.
Vote at www.ProxyVote.com Board Recommends Voting Items1. To elect two class III directors to hold office until the 2028 Annual Meeting of Stockholders. Nominees: 1a. Heidi Kunz For 1b. James Topper, M.D., Ph.D. For 2. To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025. For 3. To approve the compensation of the named executive officers on a non-binding advisory basis (“say-on-pay”). For 4. To approve a proposal for the frequency of future non-binding advisory votes on the compensation of the named executive officers (“say-on-frequency”).1YearNOTE: Such other business as may properly come before the meeting or any adjournment thereof. Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”.